US prices of some psoriasis drugs need to be lowered to match benefits, new study says
The prices of drugs for psoriasis need to be reduced by about 71% to match their efficacy, researchers from Harvard Medical School and the Brigham …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
